[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diabetes Market Research Reports & Industry Analysis

The notion “diabetes” refers to a disease impacting the body’s ability to produce/use insulin. At present, more than 365 million people suffer from the disease worldwide. By 2030, the figure may reach 550 million. Inappropriate eating habits combined with a sedentary lifestyle, growth of the diabetic population and an increase in the number of obesity cases are amid the main factors contributing to the diabetes market growth. The list of the products available on the market is extensive: continuous blood glucose meters, anti-diabetic drugs, insulin and insulin pumps, artificial pancreas devices, etc.

Evaluated at over USD 19.8 billion, North America represents the top market, while Europe acts as the second largest player. The global diabetes market is expected to be at approximately USD 100 billion in 2018, showing a twofold increase if compared to 2011.

The Catalogue includes research reports dedicated to the diabetes market. The studies describe past and current industry trends, disclose data on the market competition and profile top industry behemoths. Information on the upcoming market events, industry growth drivers and hindrances can be found in the reports, too. Besides, the research reports contain evaluation of the actual economic situation, analyses of the market prospects.

Publications found: 109
Sort by:
Pre-Diabetes Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2020 US$ 2,500.00

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2018 SUMMARY GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2018' provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report ...

March 2020 388 pages
Diabetic Nephropathy Global Clinical Trials Review, H1, 2020 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

March 2020 404 pages
Diabetic Macular Edema Global Clinical Trials Review, H1, 2020 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

March 2020 421 pages
Diabetes Devices Market Size, Share & Trends Analysis Report By Product (BGM Devices, Insulin Delivery Devices) By Distribution Channel, By End Use (Hospitals, Homecare), By Region, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

The global diabetes devices market size is expected to reach USD 35.5 billion by 2024, according to a new report by Grand View Research, Inc. The market is projected to ... were obese. Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, ...

March 2020 110 pages
Diabetic Retinopathy Global Clinical Trials Review, H1, 2020 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

February 2020 330 pages
Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2020 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

January 2020 248 pages
The 2021-2026 World Outlook for Molded Dual-Component Cushioned-Ring Flexible Seals That Are Backed, Constrained, or Loaded by an Elastomeric Ring US$ 995.00

This study covers the world outlook for molded dual-component cushioned-ring flexible seals that are backed, constrained, or loaded by an elastomeric ring across more than 190 countries. For each year reported, estimates are given for the latent ...

December 2019 328 pages
The 2021-2026 World Outlook for Naturally Occurring Vitamins in Bulk Excluding Vitamin C and Vitamin E US$ 995.00

This study covers the world outlook for naturally occurring vitamins in bulk excluding vitamin C and vitamin E across more than ... P.I.E., for naturally occurring vitamins in bulk excluding vitamin C and vitamin E. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

December 2019 316 pages
The 2021-2026 World Outlook for Non-Aerospace-Type High-Pressure Hydraulic Fluid Filter Assemblies for Fluid Power Transfer Systems with at Least 3,000 P.s.i. US$ 995.00

This study covers the world outlook for non-aerospace-type high-pressure hydraulic fluid filter assemblies for fluid power transfer systems with at least 3,000 p.s.i. across more than 190 countries. For each year reported, ...

December 2019 334 pages
The 2021-2026 World Outlook for Cloud-Based Software Solutions and Software as A Service (SaaS) US$ 995.00

This study covers the world outlook for cloud-based software solutions and software as a service (SaaS) across more than 190 ... the P.I.E., for cloud-based software solutions and software as a service (SaaS). It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

November 2019 315 pages
The 2021-2026 World Outlook for Colorectal Cancer Drugs US$ 995.00

This study covers the world outlook for colorectal cancer drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for colorectal cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

November 2019 299 pages
Digital Diabetes Management Market - Global Outlook and Forecast 2019-2024 US$ 3,500.00

The global digital diabetes management market is growing at a CAGR of over 18% during the forecast period 2018–2024. The global digital diabetes management market has witnessed significant growth in s...

November 2019 268 pages
Frontier Pharma: Type 1 Diabetes Insulin Gene Therapy and Immuno-modulators Dominate First-in-Class Pipeline with Novel Target Classes Demonstrating Potential Beta-Cell Regeneration US$ 6,995.00

Frontier Pharma: Type 1 Diabetes Insulin Gene Therapy and Immuno-modulators Dominate First-in-Class Pipeline with Novel Target Classes Demonstrating Potential Beta-Cell Regeneration SUMMARY Type 1 d...

October 2019 57 pages
China Diabetes Market Report: 2019-2024 US$ 1,999.00

... growth rates in the more developed markets have declined. According to the latest report by IMARC Group, titled “China Diabetes Market Report: 2019-2024”, the China diabetes market reached a value of US$ 3.37 Billion in 2018 ...

June 2019 92 pages
Diabetes Insipidus Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 51 pages
Diabetic Complications Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 1474 pages
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 77 pages
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 79 pages
Diabetic Hypertension Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 43 pages
Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 56 pages
Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

May 2019 56 pages
Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 175 pages
Diabetic Neuropathy Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 323 pages
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

May 2019 169 pages
Type 1 Diabetes: Epidemiology Forecast to 2026 US$ 3,995.00

Type 1 Diabetes: Epidemiology Forecast to 2026 SUMMARY Type 1 diabetes, formerly referred to as insulin-dependent diabetes, is a type of diabetes that predominantly develops ... The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of type 1 diabetes segmented by age (ages under ...

April 2019 29 pages
Japan Diabetes Market Report: 2019-2024 US$ 1,999.00

... of 4.4% during 2011-2018. The market is further projected to cross US$ 5 Billion by 2024, growing at a CAGR of 3.8% during 2019-2024. Diabetes refers to a chronic disease in which ... in the industry. Key Questions Answered in This Report: How has the Japan diabetes market performed so far and how will it perform ...

April 2019 89 pages
Global Type 2 Diabetes Treatment Market Research and Forecast, 2018-2023 US$ 3,600.00

... treatment therapies for diabetes and a strict regulatory framework that hamper the growth of the global type 2 diabetes market. Based on the region, the global type 2 diabetes ... of the World. North America dominates the global type 2 diabetes market owing to technological advancements and supportive government ...

January 2019
Diabetic Foot Ulcer (DFU) Market & Drug Pipeline Analysis - Forecast to 2025 US$ 4,950.00

“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The ... research for DFU. Market Data Forecasting model for DFU market DFU market dynamics DFU Market Sizing DFU related deals & Funding scenario in DFU market Pipeline Analysis ...

December 2018 136 pages
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

October 2018 76 pages
Type 1 Diabetes: Competitive Landscape to 2026 US$ 3,495.00

Type 1 Diabetes: Competitive Landscape to 2026 SUMMARY Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells ... impact the global Type 1 Diabetes (T1D) market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing ...

September 2018 48 pages
Global Diabetic Neuropathy Market Size study, by Types of Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), and by Regional Forecasts 2018-2025 US$ 3,150.00

Global Diabetic Neuropathy Market to reach USD 8460.3 million by 2025. Global Diabetic Neuropathy Market valued approximately USD 4680 million in 2016 is ... Target Audience of the Global Diabetic Neuropathy Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises ...

August 2018 120 pages
Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2018 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

June 2018 94 pages
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 US$ 3,995.00

... provides an overview of the pipeline landscape for diabetes and associated metabolic conditions. It provides comprehensive information on the therapeutics ... targets acted on by products in development for diabetes and associated metabolic conditions include the insulin receptor, glucagon-like peptide 1 ...

June 2018 344 pages
U.S. Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patch, CGM System, and Artificial Pancreas), Demographic (Adult Population and Child Population), Indication (Type I Diabetes and Type II Diabetes), and End User (Diagnostics/Clinic, ICU, and Home Healthcare) - U.S. Opportunity Analysis and Industry Forecast, 2014-2023 US$ 3,255.00

... skin irritation due to frequent use of needles. The U.S. next generation diabetes therapy and drug delivery market is segmented based on product type, ... analysis of the key developments in the industry. The U.S. next generation diabetes therapy and drug delivery market is comprehensively analyzed with respect to ...

April 2018 124 pages
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease US$ 6,995.00

... , alongside increases in obesity due to lifestyle changes in the 21st century. Type 2 diabetes is characterized by insulin resistance leading to dysregulation of glucose control and chronic hyperglycemia. This leads to several ...

March 2018 77 pages
Type 2 Diabetes: Competitive Landscape to 2026 US$ 3,495.00

Type 2 Diabetes: Competitive Landscape to 2026 SUMMARY Type 2 Diabetes (T2D) is a chronic disease characterized by insulin resistance and ... impact the global Type 2 Diabetes (T2D) market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing ...

February 2018 51 pages
Global Human Insulin Market 2018-2024 US$ 2,750.00

... for the manufacturers of human insulin. Market Analysis: The “Global Human Insulin” market is estimated to witness a CAGR of 10.2% during the forecast period 2017–2023. The human insulin market is analyzed based on three ...

February 2018 77 pages
Global Artificial Intelligence in Diabetes Management Market: Drivers, Restraints, Opportunities, Trends, and Forecasts to 2023 US$ 3,500.00

... within 20 years. Market Analysis According to Infoholic Research, the “Global Artificial Intelligence in Diabetes Management” market is expected to grow at a CAGR of 50.7% ... Benefits The study covers and analyzes the “Global Artificial Intelligence in Diabetes Management” market. Bringing out the complete key ...

February 2018 82 pages
Medical Affairs Reputations: Type 2 Diabetes Mellitus [Orals] (EU5) 2018 US$ 6,365.00

... the market leader In the EU5, several of the Type 2 Diabetes Mellitus medical affairs teams we surveyed are running neck and neck with ... ways you can improve your medical affair services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (EU5). Comparing 9 major Type 2 Diabetes Mellitus (Orals) ...

January 2018
Medical Affairs Reputations: Type 2 Diabetes Mellitus [Orals] (US) 2018 US$ 6,365.00

... the ways you can improve your medical affairs services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (US). Comparing 9 major oral Type 2 Diabetes Mellitus treatments from AstraZeneca ...

January 2018
India Diabetes Market Report 2017 US$ 2,350.00

... still maintained a relatively optimistic growth, the past four years, Diabetes market size to maintain the average annual growth rate of 1.96% from 401 ... ) Channel (Direct Sales, Distributor) Segmentation Section 7: 400 USD - Trend (2017-2021) Section 8: 300 USD - Product Type Detail Section 9: 700 ...

November 2017 126 pages
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth US$ 4,995.00

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth SUMMARY Diabetes mellitus ... range of treatment options, including biguanide (metformin), sulfonylureas, thiazolidinediones, GLP-1 receptor ...

September 2017 202 pages
Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes US$ 4,995.00

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape ... the diversifying and highly lucrative diabetes mellitus (DM) market. Analysis has identified a high level of ... review of products, segmented by stage of development, molecule type and molecular target - as well as detailed profile assessments ...

September 2017 137 pages
NPS+ Type 2 Diabetes Mellitus [2017] EU5 US$ 2,575.00

... does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (EU5) gives a unique insight into the overall brand health ... degludec/liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (EU5) offers valuable insight into brand loyalty from ...

August 2017
NPS+ Type 2 Diabetes Mellitus [2017] US US$ 2,575.00

... how does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (US) gives a unique insight into the overall brand health of ... (liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (US) offers valuable insight into brand loyalty from the ...

August 2017
Gestational Diabetes Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

August 2017 133 pages
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 US$ 2,500.00

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017' provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report ...

August 2017 283 pages
Diabetic Hypertension Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

July 2017 41 pages
Diabetic Complications Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

July 2017 1098 pages
Diabetes Insipidus Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

July 2017 45 pages

Filters

Search

Publishers

1
5
1
1
1
1
2
1
41
2
1
1
3
3
1
1
1
16
1
2
3
1
4
1
10
4

Regions

1
1
4
1
5
2
6
4
85

Price

Date

Pages

Offers